Compare LGIH & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LGIH | BLFS |
|---|---|---|
| Founded | 2003 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 923.5M |
| IPO Year | 2013 | 2013 |
| Metric | LGIH | BLFS |
|---|---|---|
| Price | $40.56 | $20.68 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $75.90 | $32.00 |
| AVG Volume (30 Days) | ★ 415.7K | 328.6K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | ★ 0.09 | 0.02 |
| Revenue | ★ $1,705,504,000.00 | $96,214,000.00 |
| Revenue This Year | $2.32 | $19.73 |
| Revenue Next Year | $17.94 | $17.82 |
| P/E Ratio | ★ $487.56 | $1,049.50 |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $33.55 | $17.86 |
| 52 Week High | $69.42 | $29.57 |
| Indicator | LGIH | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 39.15 | 43.77 |
| Support Level | $34.71 | $19.71 |
| Resistance Level | $41.50 | $20.47 |
| Average True Range (ATR) | 2.33 | 0.95 |
| MACD | -0.64 | -0.15 |
| Stochastic Oscillator | 1.03 | 17.85 |
LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company's current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under the LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company has seven operating segments: West, Northwest, Central, Midwest, Florida, Southeast, and Mid-Atlantic. The majority of the revenue is generated from the Central division segment.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.